5.85SAR
2.05 BSAR
9.51 BSAR
84.77 M
About DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP
Sector
Industry
CEO
Faisal Abdullah Ali Al Nassar
Website
Headquarters
Riyadh
Founded
1995
ISIN
SA1510P1UMH1
FIGI
BBG00QG4RJ32
Dr. Sulaiman Al-Habib Medical Group owns and operates a number of hospitals and medical centers. It operates through the following segments: Hospitals, Pharmacies, and HMG Solutions. The company was founded by Sulaiman Abdulaziz Al-Habib in 1995 and is headquartered in Riyadh, Saudi Arabia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 4013 is featured.
Frequently Asked Questions
The current price of 4013 is 314.80 SAR — it has decreased by 0.19% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TADAWUL exchange DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP stocks are traded under the ticker 4013.
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
4013 stock is 2.19% volatile and has beta coefficient of 1.07. Check out the list of the most volatile stocks — is DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP there?
One year price forecast for DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP has a max estimate of 345.00 SAR and a min estimate of 200.00 SAR.
4013 earnings for the last quarter are 1.20 SAR whereas the estimation was 1.17 SAR which accounts for 2.93% surprise. Estimated earnings for the next quarter are 1.23 SAR. See more details about DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP earnings.
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP revenue for the last quarter amounts to 2.44 B SAR despite the estimated figure of 2.37 B SAR. In the next quarter revenue is expected to reach 2.60 B SAR.
Yes, you can track DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP financials in yearly and quarterly reports right on TradingView.
4013 stock has risen by 0.06% compared to the previous week, the month change is a 1.32% fall, over the last year DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP has showed a 14.97% increase.
4013 net income for the last quarter is 525.01 M SAR, while the quarter before that showed 544.77 M SAR of net income which accounts for −3.63% change. Track more DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP financial stats to get the full picture.
Today DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP has the market capitalization of 110.39 B, it has increased by 4.92% over the last week.
Yes, 4013 dividends are paid quarterly. The last dividend per share was 1.15 SAR. As of today, Dividend Yield (TTM)% is 1.37%. Tracking DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP dividends might help you take more informed decisions.
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP dividend yield was 1.52% in 2023, and payout ratio reached 73.90%. The year before the numbers were 1.58% and 73.79% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4013 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP stock shows the buy signal. See more of DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP future price: according to them, 4013 price has a max estimate of 345.00 SAR and a min estimate of 200.00 SAR. Read a more detailed DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP forecast: see what analysts think of DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP EBITDA is 2.41 B SAR, and current EBITDA margin is 25.47%. See more stats in DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP financial statements.